Early MRI endpoints provide a valid measure of structural damage while reducing study duration and participant numbers in rheumatoid arthritis clinical trials.

J. Baker, P.G. Conaghan, P. Emery, D. Baker, Mikkel Østergaard

OriginalsprogEngelsk
TidsskriftArthritis & Rheumatology
Vol/bind66
Udgave nummerSuppl. 11
Sider (fra-til)S832
Antal sider1
ISSN1537-2960
StatusUdgivet - 2014

Citationsformater